Bowen Hanes & Co’s Clorox CLX Stock Holding History

Bowen Hanes & Co’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-143,717	Closed	-$27.7M	–	150
2021 Q1	$27.7M	Buy	143,717 +11,140	+8%	+$2.14M	0.89%	51
2020 Q4	$26.8M	Hold	132,577	–	–	0.89%	51
2020 Q3	$27.9M	Hold	132,577	–	–	1.01%	47
2020 Q2	$29.1M	Sell	132,577 -20,000	-13%	-$4M	1.17%	43
2020 Q1	$26.4M	Buy	+152,577	New	+$25.2M	1.29%	41

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bowen Hanes & Co's CLX Position: Q2 2021 in Review

Bowen Hanes & Co sold out of Clorox (CLX) in Q2 2021, closing a stake of 143,717 shares — an estimated $27.7M sold.

Bowen Hanes & Co first reported a position in CLX in Q1 2020 and held it in 5 quarters. The position peaked at $29.1M in Q2 2020. 1,169 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

Bowen Hanes & Co reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
Bowen Hanes & Co sold 143,717 Clorox shares in Q2 2021, an estimated $27.7M.
Bowen Hanes & Co first reported a position in Clorox in Q1 2020 and held it in 5 quarters.
Bowen Hanes & Co's Clorox position peaked at $29.1M in Q2 2020.
1,169 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Bowen Hanes & Co's 13F filing for Q2 2021, filed 12 Aug 2021.